| 27262212 | Identifying the Appropriate FISH Criteria for Defining MET Copy Number-Driven Lung Adenocarcinoma through Oncogene Overlap Analysis. (2016 Aug) | Noonan SA | J Thorac Oncol |
| 28065467 | Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases. (2017 Jul) | Rokutan-Kurata M | Clin Lung Cancer |
| 27027665 | Gene aberrations for precision medicine against lung adenocarcinoma. (2016 Jun) | Saito M | Cancer Sci |
| 26689248 | Polymorphism of rs9387478 correlates with overall survival in female nonsmoking patients with lung cancer. (2016 May 28) | Han JF | Int J Biol Markers |
| 28280984 | Treatment of lung adenocarcinoma by molecular-targeted therapy and immunotherapy. (2018 Jan) | Saito M | Surg Today |
| 25855381 | Development of lung adenocarcinomas with exclusive dependence on oncogene fusions. (2015 Jun 1) | Saito M | Cancer Res |
| 26705279 | [Detection of ALK, ROS1 and RET fusion genes in non-small cell lung cancer patients and its clinicopathologic correlation]. (2015 Sep) | Zhong S | Zhonghua Bing Li Xue Za Zhi |
| 25267753 | How long is long enough? Extended anticoagulation for the treatment of cancer-associated deep vein thrombosis. (2014 Nov 10) | Zwicker JI | J Clin Oncol |
| 29277178 | [Clinical Significance and Mechanism of PI3K p110beta Overexpression in Non-small Cell Lung Cancer]. (2017 Dec 20) | Xiong Y | Zhongguo Fei Ai Za Zhi |
| 25862146 | PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy. (2015 Jun) | Chang YL | Lung Cancer |
| 26273395 | Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements. (2015 Jul) | Wu S | Thorac Cancer |
| 26775573 | [News about targeted therapies in non-small-cell lung cancer in 2015 (except immuno-therapy)]. (2016 Jan) | Hamard C | Ann Pathol |
| 27793199 | Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China. (2016 Oct 28) | Li X | BMC Cancer |
| 27268911 | Smoking, hormonal factors and molecular markers in female lung cancer. (2016) | Schveigert D | Neoplasma |
| 23514723 | ROS1 fusions in Chinese patients with non-small-cell lung cancer. (2013 Jul) | Cai W | Ann Oncol |
| 24920890 | Pulmonary adenocarcinoma mutation profile in smokers with smoking-related interstitial fibrosis. (2014) | Primiani A | Int J Chron Obstruct Pulmon Dis |
| 24390215 | Cribriform adenocarcinoma of the lung: clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma. (2014 Aug) | Mackinnon AC Jr | Mod Pathol |
| 23788756 | The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma. (2013 Sep) | Kim HR | Ann Oncol |
| 22585869 | ROS1 gene rearrangement is identified in NSCLC. (2012 Feb) | - | Cancer Discov |
| 26955281 | The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations. (2016) | Zheng D | Onco Targets Ther |
| 29413057 | Tumor biomarker testing in non-small-cell lung cancer: A decade of change. (2018 Feb) | VanderLaan PA | Lung Cancer |
| 25870798 | Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer. (2015 Apr) | Kohno T | Transl Lung Cancer Res |
| 28468034 | [To evaluate the clinicopathologic characteristics and outcome of tumor cells spreading through air spaces in patients with adenocarcinoma of lung]. (2017 May 8) | Sun PL | Zhonghua Bing Li Xue Za Zhi |
| 28468033 | [Clinicopathologic features and genetic profile of the redefined large cell lung carcinoma]. (2017 May 8) | Hou LK | Zhonghua Bing Li Xue Za Zhi |
| 28676214 | DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel. (2017 Aug) | Takamochi K | Lung Cancer |
| 26331813 | Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population. (2015 Sep 1) | Gou LY | Cancer |
| 24300132 | Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma. (2014 Feb) | Sun JM | Lung Cancer |
| 29128428 | Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer. (2018 Jan) | Ferrara R | J Thorac Oncol |
| 28104537 | Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 >/=50% Expression in Lung Adenocarcinoma. (2017 May) | Rangachari D | J Thorac Oncol |
| 26437441 | Molecular Process Producing Oncogene Fusion in Lung Cancer Cells by Illegitimate Repair of DNA Double-Strand Breaks. (2015 Sep 30) | Seki Y | Biomolecules |
| 27438512 | Driver Mutation Analysis and PD-L1 Expression in Synchronous Double Primary Lung Cancer. (2018 Apr) | Jia X | Appl Immunohistochem Mol Morphol |
| 25567908 | Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches. (2015 Aug 15) | Drilon A | Clin Cancer Res |
| 28740441 | Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives. (2017) | Rossi G | Lung Cancer (Auckl) |
| 28881815 | Clinicopathological characteristics of ROS1- and RET-rearranged NSCLC in caucasian patients: Data from a cohort of 713 non-squamous NSCLC lacking KRAS/EGFR/HER2/BRAF/PIK3CA/ALK alterations. (2017 Aug 8) | Dugay F | Oncotarget |
| 27635639 | Clinicopathological characteristics and survival of ALK, ROS1 and RET rearrangements in non-adenocarcinoma non-small cell lung cancer patients. (2017 Nov 2) | Song Z | Cancer Biol Ther |
| 26207220 | Clinicopathologic characteristics of patients with ROS1 fusion gene in non-small cell lung cancer: a meta-analysis. (2015 Jun) | Zhu Q | Transl Lung Cancer Res |
| 28025329 | Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations. (2017 Jan 15) | Seow WJ | Hum Mol Genet |
| 23887156 | ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas. (2013 Sep) | Sholl LM | Am J Surg Pathol |
| 26601054 | Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice. (2015) | Rangachari D | Cancer Treat Commun |
| 29413048 | Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells? (2018 Feb) | Zhou F | Lung Cancer |
| 23877438 | CD74-ROS1 fusion transcripts in resected non-small cell lung carcinoma. (2013 Oct) | Matsuura S | Oncol Rep |
| 28103968 | [Gene Expression and Clinical Characteristics of Molecular Targeted Therapy in Non-small Cell Lung Cancer Patients in Shandong]. (2017 Jan 20) | Qiao X | Zhongguo Fei Ai Za Zhi |
| 29631966 | MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy. (2018 Mar 17) | Reis H | Clin Lung Cancer |
| 26164066 | Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinoma. (2015 Sep) | Preusser M | Eur J Cancer |
| 22975805 | The transcriptional landscape and mutational profile of lung adenocarcinoma. (2012 Nov) | Seo JS | Genome Res |
| 27298405 | Management of Brain Metastases in ALK-Positive Non-Small-Cell Lung Cancer. (2016 Aug 20) | Rusthoven CG | J Clin Oncol |
| 28210164 | Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives. (2016) | Leprieur EG | Lung Cancer (Auckl) |
| 27033383 | [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer]. (2016 Apr 8) | Chen LF | Zhonghua Bing Li Xue Za Zhi |
| 28914263 | Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma. (2018 Feb) | Tang Z | Mod Pathol |
| 18097620 | Association of polymorphisms of ABCA1 and ROS1 with hypertension in Japanese individuals. (2008 Jan) | Yamada Y | Int J Mol Med |
| 25007143 | Pulmonary adenocarcinoma with signet ring cell features: a comprehensive study from 3 distinct patient cohorts. (2014 Dec) | Boland JM | Am J Surg Pathol |
| 25567305 | [Detection of ROS1 gene rearrangement by FISH and analysis of its clinical features in non-small cell lung cancer patients]. (2014 Oct) | Cheng H | Zhonghua Zhong Liu Za Zhi |
| 24087953 | [Genetic predictors of myocardial infarction in subjects of young age]. (2013) | Shesternia PA | Kardiologiia |
| 24850843 | FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. (2014 Aug 1) | Wang R | Clin Cancer Res |
| 26704833 | [Detection of ROS1 fusion gene in pulmonary adenocarcinoma and its clinicopathologic features]. (2015 Jun) | Liu J | Zhonghua Bing Li Xue Za Zhi |
| 24163741 | Molecular biology of lung cancer. (2013 Oct) | Cooper WA | J Thorac Dis |
| 27708233 | Advanced lung adenocarcinomas with ROS1-rearrangement frequently show hepatoid cell. (2016 Nov 8) | Zhao J | Oncotarget |
| 28952227 | Analysis of the status of EGFR, ROS1 and MET genes in non-small cell lung adenocarcinoma. (2017 Jul-Aug) | Wang Q | J BUON |
| 27008586 | Clinicopathologic Characteristics of Patients with HER2 Insertions in Non-small Cell Lung Cancer. (2017 Jan) | Bu S | Ann Surg Oncol |
| 29217530 | The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2). (2018 Mar 1) | Aisner DL | Clin Cancer Res |
| 25180059 | Detecting ALK, ROS1 and RET Fusion Genes in Cell Block Samples. (2014 Jun) | Zhao C | Transl Oncol |